Geert-Jan Mulder MD
Managing Partner
ARMGO is a venture-backed biotech company developing Rycals®, novel small molecule drugs that target the ryanodine receptor calcium ion channels (RyR).
Industry
Biotech
Status
Realised
Forbion team
Dmitrij Hristodorov PhD
General Partner